MEI Pharma, Inc. (NASDAQ:MEIP)

CAPS Rating: No stars

A development stage company, engaged in the clinical development of the anti-cancer drug phenoxodiol.

Recs

0
Player Avatar pchop123 (79.80) Submitted: 1/10/2013 4:16:33 PM : Underperform Start Price: $7.18 MEIP Score: +3.66

management less than impressive

Featured Broker Partners


Advertisement